• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME CORPORATION SYNVISC ONE 48 MG; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME CORPORATION SYNVISC ONE 48 MG; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Lot Number 6RSL050
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bronchitis (1752); Laceration(s) (1946)
Event Type  Injury  
Event Description
Pt reported that she is currently in the hospital for chronic bronchitis and a lacerated bladder.Onset date reported as within the last 30 days.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNVISC ONE 48 MG
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
GENZYME CORPORATION
MDR Report Key10851977
MDR Text Key216894293
Report NumberMW5097923
Device Sequence Number1
Product Code MOZ
UDI-Device Identifier58468009003
UDI-Public58468-0090-03
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 04/11/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/16/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Lot Number6RSL050
Was Device Available for Evaluation? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-